BPC-157 runs $28–$65 per 5 mg vial, $45–$110 per 10 mg, and $900–$2,400 per gram. See per-milligram math, kit discounts, and why cheap listings cost more.
Reference-grade BPC-157 sold as a research material typically lists at $28–$65 for a 5 mg vial and $45–$110 for a 10 mg vial from US suppliers that publish lot-specific analytical documentation. At single-vial pricing that is roughly $5.60–$13.00 per milligram. Ten-vial kits usually land at $180–$400 for 50 mg, or about $3.60–$8.00 per milligram. Gram-scale and wholesale purchasing drops the figure further, commonly $900–$2,400 per gram depending on documentation depth and purity specification. Overseas marketplace listings appear as low as $8–$15 per 5 mg vial, but those prices almost never include a lot-matched certificate of analysis, which changes what you are actually buying.
Below is where those numbers come from, and where the sticker price stops being the useful number.
The synthesis itself is not the expensive part. BPC-157 is a 15-residue peptide (GEPPPGKPADDAGLV), and solid-phase synthesis at that length is routine chemistry. Crude peptide can be produced for well under $200 per gram at scale. The cost structure sits almost entirely downstream:
A vial labeled "5 mg" is frequently labeled by gross fill mass, not by net peptide content. Lyophilized peptide purified by RP-HPLC using trifluoroacetic acid carries a TFA counterion, and residual water and salt remain after drying. Typical net peptide content for a TFA-salt peptide is 75–90% of gross mass. That means a 5 mg gross fill may contain 3.75–4.50 mg of actual peptide.
Run the arithmetic on two hypothetical listings:
| Listing | Sticker | Stated purity | Net content | True $/mg peptide |
|---|---|---|---|---|
| Supplier A, 5 mg | $32 | 99.1% | 87% (documented) | $7.51 |
| Supplier B, 5 mg | $19 | "≥98%" (no COA) | Unstated | $4.37 if 87%, $6.33 if 60% |
Supplier B looks 41% cheaper. If net content is unstated and the lot turns out to be 60% peptide by mass, the real gap narrows to about 16% — and you have no document proving either figure. Purity by HPLC area percent and peptide content by mass are two different measurements, and a COA that reports only the first is answering half the question.
The only price that means anything is the price per milligram you can prove is in the vial.
Independently re-testing a lot you already bought costs money. Current contract-lab pricing for a single sample:
A full independent characterization package is therefore $400–$900 and two to three weeks. Against a $19 vial, verification costs 20–47× the material. That inversion is the entire argument for paying a premium to a supplier that already did the work and will hand you the chromatogram, the mass spectrum, the lot number, and the retention time. Our own approach to per-lot release testing is documented on the quality page, and the sourcing comparison in best BPC 157 made in USA covers what domestic synthesis does and does not change about the price.
The failure cost is larger than the testing cost. If a 12-week study runs on an unverified lot and the material turns out to be 71% pure with a +18 Da mass adduct, the loss is not the $19 vial. It is the animal cohort, the technician hours, the reagents, and the calendar time — routinely $3,000–$40,000 for a small academic study, and unrecoverable.
Some purchases genuinely do not justify a premium lot, and pretending otherwise would be dishonest.
Plainly: research-use-only material is not a cheaper version of a pharmaceutical product, and no price tier changes that.
Budget the material as one line among several. A representative small research project consuming 40 mg:
Total realistic range: $728–$1,565, of which the peptide itself is 25–35%. Suppliers competing purely on the $19-vs-$32 line are competing over roughly 2% of the project budget.
Reasonable expectations as of mid-2026, per milligram, for material with a lot-matched COA:
Prices below roughly $2.50 per milligram at retail vial quantity are difficult to reconcile with per-lot analytical release at small batch sizes. That does not automatically mean the material is poor — it means the analytical cost was either amortized across a very large lot or not incurred, and the listing should tell you which. If it doesn't, ask. Specification questions go through contact, and the broader supplier-evaluation criteria are laid out in quality research chemicals suppliers.
Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.
Purity, identity and lot number, documented for the exact vial you receive.